Zymeworks Inc.
▲ 0 upgrades / ▼ 0 downgrades / 2 reiterations from 2 firms
Nov 9, 2026 (14 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Sep 29, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Sep 17, 2026 | Wolfe Research | initiate | — → Outperform | — | 53% |
| Sep 3, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Aug 26, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 26, 2026 | Citizens | reiterate | Market Outperform → Market Outperform | — | 47% |
| Aug 26, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 10, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 55% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Aug 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 5, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 7, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jun 30, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Jun 3, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 8, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 9, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Mar 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 3, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Mar 3, 2026 | Leerink Partners | maintain | Outperform → Outperform | — | 51% |
| Dec 17, 2025 | Truist Securities | initiate | — → Buy | $40 | 54% |
| Dec 12, 2025 | Wells Fargo | upgrade | Equal-Weight → Overweight | $33 | 54% |
| Dec 3, 2025 | Citizens | initiate | — → Market Outperform | $32 | 47% |
| Nov 21, 2025 | B. Riley Securities | reiterate | Buy → Buy | $40 | 55% |
| Nov 19, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $25 | 54% |
| Nov 19, 2025 | Stifel | maintain | Buy → Buy | $40 | 53% |
| Nov 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $32 | 44% |
| Nov 7, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $17 | 54% |
| Oct 16, 2025 | JP Morgan | maintain | Overweight → Overweight | $23 | 54% |
| Oct 14, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $26 | 44% |
| Oct 10, 2025 | B. Riley Securities | initiate | — → Buy | $30 | 55% |
| Aug 11, 2025 | Citigroup | maintain | Buy → Buy | $22 | 54% |
| Jul 3, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $13 | 44% |
| May 20, 2025 | TD Securities | initiate | — → Buy | $0 | 54% |
| Mar 11, 2025 | LifeSci Capital | initiate | — → Outperform | $30 | 57% |
| Mar 10, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $13 | 44% |
| Mar 7, 2025 | Citigroup | maintain | Buy → Buy | $19 | 54% |
| Dec 19, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $14 | 54% |
| Dec 16, 2024 | JP Morgan | upgrade | Neutral → Overweight | $18 | 54% |
| Nov 22, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $12 | 44% |
| Nov 7, 2024 | Leerink Partners | upgrade | Market Perform → Outperform | $25 | 51% |
| Nov 4, 2024 | Citigroup | maintain | Buy → Buy | $18 | 54% |
| Nov 1, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $12 | 44% |
| Nov 1, 2024 | Wells Fargo | downgrade | Overweight → Equal-Weight | $12 | 54% |
| Oct 28, 2024 | Stifel | maintain | Buy → Buy | $28 | 53% |
| Aug 2, 2024 | Stifel | maintain | Buy → Buy | $21 | 53% |
| Jun 6, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $10 | 44% |
| May 7, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $10 | 44% |
| May 3, 2024 | Citigroup | maintain | Buy → Buy | $16 | 54% |
| May 3, 2024 | Wells Fargo | maintain | Overweight → Overweight | $12 | 54% |
| Mar 12, 2024 | Wells Fargo | maintain | Overweight → Overweight | $14 | 54% |
No cross-platform signals in the last 90 days